Intracranial Pressure and Cerebral Edema

Intracranial pressure is not the disease

ICP and CPP are useful bedside guardrails, not isolated treatment goals. Management requires integrating pressure burden over time with compliance, autoregulation, venous outflow, carbon dioxide, oxygen delivery, imaging, and examination so that lowering a monitor value does not create a new secondary brain insult.

Read the full post →

Principles of Osmotherapy

Osmotherapy can rapidly reduce intracranial volume and buy time during a pressure crisis, but it does not treat the underlying injury or clearly improve long-term neurologic outcome. Agent selection and repeat dosing should follow the patient’s systemic physiology and measured response.

Read the full post →

Osmotherapy: Chips vs Cupcakes

Osmotherapy creates a temporary osmotic gradient; agent choice should follow CPP, volume, renal, sodium, and chloride physiology—not an assumed outcome advantage. Hypertonic saline and mannitol lower ICP, but neither has demonstrated superior long-term neurologic outcomes, so every dose must produce a measurable physiologic response.

Read the full post →

Cerebral Edema Management

Cerebral edema management begins by identifying which intracranial compartment is expanding and which definitive intervention temporary ICP reduction must support. Osmotherapy, ventilation, sedation, and CSF drainage can buy time, but lowering ICP alone does not establish neurological benefit.

Read the full post →

Cerebral Herniation

Cerebral herniation is a movement syndrome driven by dangerous pressure gradients, not simply a high ICP. Hyperventilation, osmotherapy, and CSF drainage may buy time, but definitive treatment must correct the pressure-generating compartment—and survival does not necessarily guarantee functional independence.

Read the full post →

Refractory Intracranial Hypertension

Refractory intracranial hypertension is not defined by one ICP threshold. Rescue therapies must be judged by whether they preserve perfusion, oxygen delivery, and viable brain, recognizing that reduced mortality may produce survival across a broad disability spectrum.

Read the full post →

Joshua Lukas, MD (Instagram: @Neurointensivist)

Leave a Reply